TRIM8 modulates p53 activity to dictate cell cycle arrest

Cell Cycle

Volumn 11, Issue 3, 2012, Pages 511-523

  Caratozzolo, Mariano Francesco ^a   Micale, Lucia ^b   Turturo, Maria Giuseppina ^b,e   Cornacchia, Silvia ^a,c   Fusco, Carmela ^b   Marzano, Flaviana ^a,c   Augello, Bartolomeo ^b   D'Erchia, Anna Maria ^c   Guerrini, Luisa ^d   Pesole, Graziano ^a,c   Sbisà, Elisabetta ^a   Merla, Giuseppe ^b   Tullo, Apollonia ^a  

^a CNR   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e TELETHON INSTITUTE OF GENETICS AND MEDICINE TIGEM   (Italy)

Author keywords

Cell fate; p53; Stress response; TRIM8; Tumor suppressor

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; PROTEIN; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; TRIPARTITE MOTIF PROTEIN 8; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL PROLIFERATION; CELL STRESS; CONTROLLED STUDY; DNA REPAIR; GENE; GENE ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIATION EXPOSURE; TUMOR SUPPRESSOR GENE; ULTRAVIOLET RADIATION;

EID: 84857203452     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.11.3.19008     Document Type: Article

References (39)

1. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408:307-10; PMID:11099028; http://dx.doi.org/10.1038/35042675.
2. Lane D, Levine A. p53 Research: the past thirty years and the next thirty years. Cold Spring Harb Perspect Biol 2010; 2:893; PMID:20463001; http://dx.doi.org/10.1101/cshperspect.a000893.
3. Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008; 9:402-12; PMID:18431400; http://dx.doi.org/10.1038/nrm2395.
4. Li M, Brooks CL, Wu-Baer F, Chen D, Baer R, Gu W. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science 2003; 302:1972-5; PMID:14671306; http://dx.doi.org/10.1126/science.1091362.
5. Brooks CL, Gu W. p53 ubiquitination: Mdm2 and beyond. Mol Cell 2006; 21:307-15; PMID:16455486; http://dx.doi.org/10.1016/j.molcel.2006.01.020.
6. Marchenko ND, Wolff S, Erster S, Becker K, Moll UM. Monoubiquitylation promotes mitochondrial p53 translocation. EMBO J 2007; 26:923-34; PMID:17268548; http://dx.doi.org/10.1038/sj.emboj.7601560.
7. Wu H, Leng RP. UBE4B, a ubiquitin chain assembly factor, is required for MDM2-mediated p53 polyubiquitination and degradation. Cell Cycle 2011; 10:1912-5; PMID:21558803; http://dx.doi.org/10.4161/cc.10.12.15882.
8. Pang LY, Scott M, Hayward RL, Mohammed H, Whitelaw CB, Smith GC, et al. p21(WAF1) is component of a positive feedback loop that maintains the p53 transcriptional program. Cell Cycle 2011; 10:932-50; PMID:21368573; http://dx.doi.org/10.4161/cc.10.6.15012.
9. Llanos S, Serrano M. Depletion of ribosomal protein L37 occurs in response to DNA damage and activates p53 through the L11/MDM2 pathway. Cell Cycle 2010; 9:4005-12; PMID:20935493; http://dx.doi.org/10.4161/cc.9.19.13299.
10. Miliani de Marval PL, Zhang Y. The RP-Mdm2-p53 pathway and tumorigenesis. Oncotarget 2011; 2:234-8; PMID:21406728.
11. Lo D, Lu H. Nucleostemin: Another nucleolar "Twister" of the p53-MDM2 loop. Cell Cycle 2010; 9:3227-32; PMID:20703089; http://dx.doi.org/10. 4161/cc.9.16.12605.
12. Inuzuka H, Fukushima H, Shaik S, Wei W. Novel insights into the molecular mechanisms governing Mdm2 ubiquitination and destruction. Oncotarget 2010; 1:685-90; PMID:21317463.
13. Le Cam L, Linares LK, Paul C, Julien E, Lacroix M, Hatchi E, et al. E4F1 is an atypical ubiquitin ligase that modulates p53 effector functions independently of degradation. Cell 2006; 127:775-88; PMID:17110336; http://dx.doi.org/10.1016/j.cell.2006.09.031.
14. Gostissa M, Hengstermann A, Fogal V, Sandy P, Schwarz SE, Scheffner M, et al. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J 1999; 18:6462-71; PMID:10562558; http://dx.doi.org/10.1093/emboj/18.22.6462.
15. Watson IR, Irwin MS. Ubiquitin and ubiquitinlike modifications of the p53 family. Neoplasia 2006; 8:655-66; PMID:16925948; http://dx.doi.org/10.1593/neo. 06439.
16. Weger S, Hammer E, Heilbronn R. Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo. FEBS Lett 2005; 579:5007-12; PMID:16122737; http://dx.doi.org/10.1016/j.febslet.2005.07.088.
17. Bischof O, Schwamborn K, Martin N, Werner A, Sustmann C, Grosschedl R, et al. The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis. Mol Cell 2006; 22:783-94; PMID:16793547; http://dx.doi.org/10.1016/j. molcel.2006.05.016.
18. Chu Y, Yang X. SUMO E3 ligase activity of TRIM proteins. Oncogene 2011; 30:1108-16; PMID:20972456; http://dx.doi.org/10.1038/onc.2010.462.
19. Stindt MH, Carter S, Vigneron AM, Ryan KM, Vousden KH. MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity. Cell Cycle 2011; 10:3176-88; PMID:21900752; http://dx.doi.org/10.4161/cc.10.18.17436.
20. Harper JW. Neddylating the guardian; Mdm2 catalyzed conjugation of Nedd8 to p53. Cell 2004; 118:2-4; PMID:15242638; http://dx.doi.org/10.1016/j.cell. 2004.06.015.
21. Meroni G, Diez-Roux G. TRIM/RBCC, a novel class of 'single protein RING finger' E3 ubiquitin ligases. Bioessays 2005; 27:1147-57; PMID:16237670; http://dx.doi.org/10.1002/bies.20304.
22. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L, et al. The tripartite motif family identifies cell compartments. EMBO J 2001; 20:2140-51; PMID:11331580; http://dx.doi.org/10.1093/emboj/20.9.2140.
23. Avela K, Lipsanen-Nyman M, Idänheimo N, SeemanováE, Rosengren S, Mäkelä TP, et al. Gene encoding a new RING-B-box-Coiled-coil protein is mutated in mulibrey nanism. Nat Genet 2000; 25:298-301; PMID:10888877; http://dx.doi.org/10.1038/77053.
24. Frosk P, Weiler T, Nylen E, Sudha T, Greenberg CR, Morgan K, et al. Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene. Am J Hum Genet 2002; 70:663-72; PMID:11822024; http://dx.doi.org/10.1086/339083.
25. Micale L, Fusco C, Augello B, Napolitano LM, Dermitzakis ET, Meroni G, et al. Williams-Beuren syndrome TRIM50 encodes an E3 ubiquitin ligase. Eur J Hum Genet 2008; 16:1038-49; PMID:18398435; http://dx.doi.org/10.1038/ejhg.2008.68.
26. Quaderi NA, Schweiger S, Gaudenz K, Franco B, Rugarli EI, Berger W, et al. Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22. Nat Genet 1997; 17:285-91; PMID:9354791; http://dx.doi.org/10.1038/ng1197-285.
27. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004; 427:848-53; PMID:14985764; http://dx.doi.org/10.1038/ nature02343.
28. Carinci F, Arcelli D, Lo Muzio L, Francioso F, Valentini D, Evangelisti R, et al. Molecular classification of nodal metastasis in primary larynx squamous cell carcinoma. Transl Res 2007; 150:233-45; PMID:17900511; http://dx.doi.org/10.1016/j.trsl.2007.03.011.
29. Shieh SY, Taya Y, Prives C. DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization. EMBO J 1999; 18:1815-23; PMID:10202145; http://dx.doi.org/10.1093/emboj/18.7. 1815.
30. Saito S, Yamaguchi H, Higashimoto Y, Chao C, Xu Y, Fornace AJ Jr, et al. Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. J Biol Chem 2003; 278:37536-44; PMID:12860987; http://dx.doi.org/10.1074/jbc.M305135200.
31. Feng L, Hollstein M, Xu Y. Ser46 phosphorylation regulates p53-dependent apoptosis and replicative senescence. Cell Cycle 2006; 5:2812-9; PMID:17172844; http://dx.doi.org/10.4161/cc.5.23.3526.
32. Sbisà E, Catalano D, Grillo G, Licciulli F, Turi A, Liuni S, et al. p53FamTaG: a database resource of human p53, p63 and p73 direct target genes combining in silico prediction and microarray data. BMC Bioinformatics 2007; 8:20; PMID:17430565; http://dx.doi.org/10.1186/1471-2105-8-S1-S20.
33. Li Q, Yan J, Mao AP, Li C, Ran Y, Shu HB, et al. Tripartite motif 8 (TRIM8) modulates TNFα- and IL-1β-triggered NFκB activation by targeting TAK1 for K63-linked polyubiquitination. Proc Natl Acad Sci USA 2011; 108:19341-6; PMID:22084099; http://dx.doi.org/10.1073/pnas.1110946108.
34. Allton K, Jain AK, Herz HM, Tsai WW, Jung SY, Qin J, et al. Trim24 targets endogenous p53 for degradation. Proc Natl Acad Sci USA 2009; 106:11612-6; PMID:19556538; http://dx.doi.org/10.1073/pnas.0813177106.
35. Jain AK, Barton MC. Regulation of p53: TRIM24 enters the RING. Cell Cycle 2009; 8:3668-74; PMID:19844164; http://dx.doi.org/10.4161/cc.8.22.9979.
36. Alsheich-Bartok O, Haupt S, Alkalay-Snir I, Saito S, Appella E, Haupt Y. PML enhances the regulation of p53 by CK1 in response to DNA damage. Oncogene 2008; 27:3653-61; PMID:18246126; http://dx.doi.org/10.1038/sj.onc.1211036.
37. Yuan Z, Villagra A, Peng L, Coppola D, Glozak M, Sotomayor EM, et al. The ATDC (TRIM29) protein binds p53 and antagonizes p53-mediated functions. Mol Cell Biol 2010; 30:3004-15; PMID:20368352; http://dx.doi.org/10.1128/MCB.01023- 09.
38. Lefkimmiatis K, Caratozzolo MF, Merlo P, D'Erchia AM, Navarro B, Levrero M, et al. p73 and p63 sustain cellular growth by transcriptional activation of cell cycle progression genes. Cancer Res 2009; 69:8563-71; PMID:19861536; http://dx.doi.org/10.1158/0008-5472.CAN-09-0259.
39. Sbisà E, Mastropasqua G, Lefkimmiatis K, Caratozzolo MF, D'Erchia AM, Tullo A. Connecting p63 to cellular proliferation: the example of the adenosine deaminase target gene. Cell Cycle 2006; 5:205-12; PMID:16410722; http://dx.doi.org/10.4161/cc.5.2.2361.